Carl N. Kraus - Aug 9, 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Medical Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Aug 9, 2024
Transactions value $
-$37,109
Form type
4
Date filed
8/12/2024, 02:45 PM
Previous filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Tax liability -$37.1K -10.8K -4.12% $3.43 252K Aug 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.